|Articles|May 8, 2020
Analysing Bevacizumab, its aggregates and fragments
The dedicated SEC column for antibodies, YMC-SEC MAB, is used to separate the MAb monomer from its aggregates as well as from degradation products in a single run.
Related Content
Trending on LCGC International
1
How AI and Machine Learning Are Reshaping Separations Science at HPLC 2026
2
ASMS 2026 Award Winners Highlight the Future of Mass Spectrometry
3
GC-MS Detection of Microbes in Spacecraft Water
4
Best of the Week: Chromatography Methods, HPLC 2026 Previews, and More
5